Credit Suisse’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.7M | Buy |
|
|||||
|
2023
Q4 | $455K | Sell |
|
|||||
|
2023
Q3 | $358K | Sell |
|
|||||
|
2023
Q2 | $898K | Buy |
|
|||||
|
2023
Q1 | $740K | Buy |
|
|||||
|
2022
Q4 | $954K | Buy |
|
|||||
|
2022
Q3 | $497K | Buy |
|
|||||
|
2022
Q2 | $360K | Sell |
|
|||||
|
2022
Q1 | $492K | Buy |
|
|||||
|
2021
Q4 | $633K | Buy |
|
|||||
|
2021
Q3 | $572K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $235K | Sell |
|
|||||
|
2020
Q4 | $642K | Buy |
|